MAR 28, 2020 3:12 PM PDT

Could the Blood of Coronavirus Survivors Save Lives?

WRITTEN BY: Annie Lennon

As the search for a treatment for coronavirus continues, a perhaps obscure-sounding candidate has begun to make headlines: blood containing antibodies from patients who have already recovered from the virus. But could this really work? 

So far, early results from China are promising. Although yet to be peer-reviewed, a preliminary paper by researchers in Beijing, Wuhan and Shanghai found that 10 severely ill patients given blood plasma from patients already recovered from COVD-19 saw their symptoms significantly improve within three days. More than this, in seven of the patients, after just six days, their viral loads dropped to undetectable levels.

Another paper found that five critically ill people who underwent the same therapy in Shenzhen saw their symptoms dramatically improve within just a few days, while their viral loads dropped within two weeks. While four of the patients no longer needed mechanical ventilation nine days following the transfusions, three have since been discharged, while the remaining two were in a stable condition as of 37 days following the transfusion. 

Although preliminary results from relatively small sample sizes, should these results be replicated over larger study samples, the treatment may be able to significantly curb the virus’s mortality rate. As such, some medical centres such as Mount Sinai and other New York hospitals have already begun to trial the treatment, while researchers are currently trying to get approval for formal and rigorous clinical trials to better collect data about the therapy. 

Michael Joyner, a Mayo Clinic anesthesiologist said, “Historical evidence suggests if you can give it to people relatively early in the course of the hospitalization, before they’re in the ICU, that might be the sweet spot for administration.”

Whether this treatment is really a panacea however will take time to tell. After all, questions still remain on the immunity of anyone who recovers; specifically, whether they may catch the virus again. Furthermore, although it is presumed that antibodies should be effective for many months, if not years, against reinfection based on research conducted on related viruses, the possibility remains that this may not be the case until further evidence emerges. 


Sources: JAMA Network, BuzzFeed News and The New York Times

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
NOV 25, 2021
Immunology
What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?
NOV 25, 2021
What's a T Cell COVID Vaccine and Could It Be Better Than What We Have?
All vaccines train the immune system to recognize and wage war against pathogens such as viruses and bacteria. However, ...
DEC 10, 2021
Drug Discovery & Development
Blood from Physically-active Boosts Memory in Sedentary Mice
DEC 10, 2021
Blood from Physically-active Boosts Memory in Sedentary Mice
Sedentary mice experience reduced neuroinflammation and improved cognitive abilities after receiving blood from physical ...
DEC 29, 2021
Drug Discovery & Development
Drug discovery and development for treating river blindness
DEC 29, 2021
Drug discovery and development for treating river blindness
Onchocerciasis, also known as river blindness, is a parasitic disease caused by the filarial nematode Onchocerca vo ...
JAN 01, 2022
Health & Medicine
Novavax's More Traditional COVID-19 Vaccine Gets Approval From European Commission and World Health Organization
JAN 01, 2022
Novavax's More Traditional COVID-19 Vaccine Gets Approval From European Commission and World Health Organization
Novavax, a Maryland-based biotechnology company, gets approval for its more traditional protein-subunit COVID-19 vaccine ...
JAN 04, 2022
Chemistry & Physics
A New Method to Lengthen Drug Life
JAN 04, 2022
A New Method to Lengthen Drug Life
Deuterium, an isotope of hydrogen, is being used to extend the lifetime of pharmaceuticals. New research published in An ...
JAN 11, 2022
Cannabis Sciences
Cannabis Varieties Used in Research Vary Significantly from Consumer Varieties
JAN 11, 2022
Cannabis Varieties Used in Research Vary Significantly from Consumer Varieties
Until just days ago, the University of Mississippi (UM) monopolized the cannabis research industry. Through a contract e ...
Loading Comments...